Company Filing History:
Years Active: 1992
Title: Edna S Dickinson: Innovator in HIV Treatment and Diagnosis
Introduction
Edna S Dickinson is a prominent inventor based in Seattle, WA, known for her significant contributions to the field of medical research, particularly in the treatment and diagnosis of HIV. With a focus on developing monoclonal antibodies and peptides, her work has the potential to impact countless lives.
Latest Patents
Edna holds a patent for "Monoclonal antibodies and peptides useful in treating and diagnosing HIV." This patent outlines methods and compositions for HIV diagnosis and treatment using monoclonal antibodies that react with one or more neutralizing regions of HIV proteins. The invention includes peptides or homologs from these regions and related nucleic acid segments. Notably, exemplary neutralizing regions include selected portions of the env and gag genes from various HIV isolates. The patent also details monoclonal antibody secreting cell lines, including HIV-gp110-1, -2, -3, -4, -5, and -6, as well as HIV-p25-2, -3, -6, and -7.
Career Highlights
Edna has made remarkable strides in her career, working with Bristol-Myers Squibb Company, a leading pharmaceutical firm. Her innovative research has positioned her as a key figure in the development of therapies aimed at combating HIV.
Collaborations
Throughout her career, Edna has collaborated with notable colleagues, including Mary K Shriver and Larry H Gosting. These partnerships have fostered an environment of innovation and have contributed to the advancement of her research.
Conclusion
Edna S Dickinson's work in the field of HIV treatment and diagnosis exemplifies the impact of innovative research on public health. Her contributions through patents and collaborations continue to pave the way for advancements in medical science.